FDA Finally Budges: New Sunscreen Arrives

Americans have been slathering on the same sunscreen ingredients for over two decades — but that just changed, and what took so long is a story worth knowing.

Quick Take

  • The Food and Drug Administration (FDA) approved bemotrizinol in June 2026, the first new sunscreen active ingredient cleared in more than 20 years.
  • Bemotrizinol has been used safely in Europe for decades and blocks both UVA and UVB rays more broadly than many older ingredients.
  • The FDA reviewed safety and effectiveness data before formally adding it to the list of permitted sunscreen ingredients.
  • Products with bemotrizinol won’t hit store shelves immediately — manufacturers now decide when and how to use it.

Why It Took 20 Years to Get Here

The U.S. sunscreen market has been stuck in a regulatory bottleneck for a long time. While Europeans and Australians have had access to a wider range of UV filters for years, Americans were limited to a short list of ingredients, most approved before 1999.

The FDA regulates sunscreen as an over-the-counter drug, not a cosmetic. That means any new ingredient has to clear a formal review process — one that proved slow and expensive enough to discourage most manufacturers from even trying.

The logjam started breaking in 2014 when Congress passed a law designed to speed up sunscreen ingredient reviews. Even then, it took over a decade for the first ingredient to make it all the way through.

Bemotrizinol, known in scientific literature by the abbreviation BEMT, became the first new ingredient evaluated under that updated process. [10] The FDA’s own scientific review, completed in late 2025, formally found bemotrizinol to be generally recognized as safe and effective for sunscreen use. [11]

What Bemotrizinol Actually Does Differently

Most Americans are familiar with zinc oxide and titanium dioxide — the white, chalky physical blockers — or older chemical filters like avobenzone. Bemotrizinol is an oil-soluble chemical filter that absorbs both UVA and UVB rays. [9]

That dual-spectrum coverage matters because UVA rays drive premature aging and contribute to skin cancer risk, while UVB rays cause sunburn. Many current single-filter ingredients handle one better than the other. Bemotrizinol handles both well, which is why dermatologists have been eager to see it approved. [7]

It also holds up better in sunlight than some older chemical filters. Avobenzone, a common UVA blocker in U.S. sunscreens, breaks down with sun exposure unless stabilized by other ingredients. Bemotrizinol is considered photostable, meaning it keeps working without degrading as quickly. [9] For consumers, that translates to more reliable protection over the course of a day outdoors — which is the whole point.

The FDA’s Decision Was Based on Real Data

Some regulatory approvals raise fair questions about whether the science was truly thorough. This one looks solid. The FDA reviewed clinical data on how bemotrizinol behaves in the body, including how much absorbs into the bloodstream. [10]

The agency’s scientific review team concluded the ingredient meets the safety and effectiveness standard required for over-the-counter sunscreen use. [11] The American Academy of Dermatology Association backed the FDA’s move, calling it a step forward for public health. [6] That kind of professional consensus, combined with decades of safe use in Europe, makes the approval look well-grounded.

The FDA’s formal addition of bemotrizinol to the permitted ingredients list means manufacturers can now formulate products with it and bring them to market. [5] Timing is up to the companies.

Expect to see it show up on ingredient labels within the next year or two as brands reformulate existing products or launch new ones. When you see it, it’s worth knowing the science behind it is more thorough than what passed muster in decades past.

What This Means When You Shop for Sunscreen

You don’t need to throw out your current sunscreen. The products on shelves today still work. But this approval opens the door to better formulas — ones that may feel lighter, cover a broader UV range, and hold up longer under real-world conditions.

Skin cancer is the most commonly diagnosed cancer in the United States. Anything that makes people more likely to actually wear sunscreen — because it feels better or works better — is a genuine public health win. The FDA moved slowly here, but it moved in the right direction.

Sources:

[5] Web – Sunscreen: How to Help Protect Your Skin from the Sun – FDA

[6] Web – FDA proposes first new sunscreen filter in 26 years

[7] Web – Sunscreen: Philly dermatologists explain new ingredient, advice

[9] Web – Bemotrizinol: What Does This New Sunscreen Ingredient Mean for …

[10] Web – Preliminary clinical pharmacokinetic evaluation of bemotrizinol

[11] Web – [PDF] US Food and Drug Administration